Merck & Co.
Ad
related to: Pfizerpfizer.com has been visited by 10K+ users in the past month
Learn more about COVID-19 vaccine, SV40 and DNA mutation. There is no evidence to support that the COVID-19 vaccine causes infertility.
- Oncology Innovation
Pfizers plan for its global fight
against cancer Pfizer is working...
- Innovations in Oncology
Learn About The Latest Oncology
Innovations At pfizer.
- Cancer Breakthroughs
The company is positioned to
deliver potential cancer...
- Cancer and Covid vaccine
There is no evidence to support
that the COVID-19 vaccine causes...
- Oncology Innovation
Search results
For 175 years, Pfizer has been a trusted partner in healthcare – discovering, developing, and delivering medical breakthroughs to prevent, treat, and cure some of the world’s most vexing conditions and diseases.
Pfizer Canada strives to profoundly impact the health of Canadians through the discovery, development and delivery of medicines and vaccines. Our diverse portfolio offers a broad range of benefits and solutions to meet the needs of Canadians.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
- On This Page
- Who The Vaccine Is Approved For
- Effectiveness
- Dosage
- Vaccine Ingredients
- Possible Side Effects
- Vaccine Review, Approval and Monitoring
- Related Links
Pfizer-BioNTech Comirnaty®COVID-19 vaccine The vaccine is approved for people who are 6 months of age and older. Its safety and effectiveness in people younger than 6 months of age have not yet been established. This vaccine is also approved as a booster for people age 5 to 11 years as well as 16 years and older. Pfizer-BioNTech Comirnaty®Original ...
Original strain
Clinical trials showed that beginning 1 week after the second dose, the Pfizer-BioNTech Comirnaty®COVID vaccine was about: 1. 95% effective in protecting trial participants from COVID-19 for those 16 years and older 2. 100% effective for those 12 to 15 years old 3. 90.7% effective for those 5 to 11 years old Effectiveness data supporting the authorization in children ages 6 months to under 5 years are based on a comparison of immune responses in this age group to individuals ages 16 to 25 yea...
Bivalent
1. The Pfizer-BioNTech Comirnaty®Original and Omicron BA.4/BA.5, bivalent COVID-19 vaccine was shown to increase the immune response against the Omicron BA.4/BA.5 variants. This means that the primary series and booster is expected to offer protection against these variants. 2. The Pfizer-BioNTech Comirnaty®Original and Omicron BA.1, bivalent COVID-19 vaccine was shown to increase the immune response against the Omicron BA.1 variant. This means that the booster is expected to offer protection...
Mixed dose schedules
A different vaccine may be offered for your second dose, if appropriate. For example, you may have received Pfizer-BioNTech Comirnaty® as your first dose and be offered Moderna Spikevax®as your second. This is known as a mixed vaccine series. The National Advisory Committee on Immunization (NACI) recommends an mRNA vaccine (Pfizer-BioNTech Comirnaty® or Moderna Spikevax®) should be offered for your second dose. Learn more about: 1. mRNA vaccines 2. Viral vector vaccines
Vials with a purple cap and purple label border contain 6 doses of 0.3 mL after dilution. One dose (0.3 mL) contains 30 micrograms of COVID-19 mRNA vaccineVials with a grey cap and grey label border contain 6 doses of 0.3 mL (does not require dilution). One dose (0.3 mL) contains 30 micrograms of COVID-19 mRNA vaccineVials with an orange cap and orange label border contain 10 doses of 0.2 mL after dilution. One dose (0.2 mL) contains 10 micrograms of COVID-19 mRNA vaccineVials with an orange cap and orange Original and Omicron label border contain 10 doses of 0.2 mL after dilution. One dose (0.2 mL) contains 10 micrograms of COVID-19 Bivalent mRNA vaccine.After getting vaccinated, it's common to have temporary side effects. These can last a few hours to a few daysafter vaccination. This is the body's immune response, as it's working hard to build protection against the disease.
Health Canada's independent drug review process is recognized around the world for its high standards and rigor. Our decisions are based only on scientific and medical evidence showing that vaccines are safe and effective. The benefits must also outweigh any risks. The Pfizer-BioNTech COVID-19 vaccine was authorized for use in Canada under the Inte...
Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age whose ...
Our Products. Our diversified health care portfolio includes some of the world’s best-known prescription medicines and vaccines. If you encounter difficulties in viewing our product information please refer to the Health Canada Drug Product Database site.
pfizer-biontech covid-19 vaccine (covid-19 mrna vaccine) On September 16, 2021, Health Canada granted full approval (Notice of Compliance or NOC) for COMIRNATY™. The vaccine was initially authorized for use in Canada under an Interim Order Authorization on December 9, 2020 under the name Pfizer-BioNTech COVID-19 Vaccine.
Ad
related to: Pfizerpfizer.com has been visited by 10K+ users in the past month
Learn more about COVID-19 vaccine, SV40 and DNA mutation. There is no evidence to support that the COVID-19 vaccine causes infertility.
